Clinico-hematological profile of patients with B-chronic lymphoid leukemia in Pakistan

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 2, 2015, Pages 793-796

  Zeeshan, Rozina ^a   Sultan, Sadia ^a   Irfan, Syed Muhammad ^a   Kakar, Jamaludin ^a   Hameed, Muhammad Asif ^a  

^a CIVIL HOSPITAL   (Pakistan)

Author keywords

B CLL; Chronic lymphoid leukemia; Clinico hematological; Pakistan

Indexed keywords

ADULT; AGED; BLOOD EXAMINATION; CANCER STAGING; CROSS-SECTIONAL STUDY; FEMALE; FOLLOW UP; HUMAN; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; PAKISTAN; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HEMATOLOGIC TESTS; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; NEOPLASM STAGING; PAKISTAN; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 84925428364     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.2.793     Document Type: Article

References (26)

1. Agrawal N, Naithani R, Mahapatra M, et al (2007). Chronic lymphocytic leukemia in India - a clinico-haematological profile. Hematology, 12, 229-33.
2. D'Arena G, Tarnani M, Rumi C, et al (2007). Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia. Am J Hematol, 82, 787-91.
3. Dodhy MA, Zafar H, Aslam W (2011). Chronic Lymphocytic Leukemia: an Experience of a decade at a Tertiary Care Hospital. Ann Pak Inst Med Sci, 7, 196-9.
4. Ehsan A, Lone A, Khan MA (2013). Autoimmune complications in chronic lymphocytic leukemia: a single center experience. Biomedica, 29, 37-41.
5. Ghosh J, Singh RK, Saxena R, et al (2013). Prevalence and aetiology of anaemia in lymphoid malignancies. Natl Med J India, 26, 79-81.
6. Gogia, A. Sharma, V. Raina, et al (2011). Clinico-hematological characteristics and outcome assessment of patients with chronic lymphocytic leukemia. J Clin Oncol, 29, 2011.
7. Gribben JG (2008). Molecular profiling in CLL. Hematology Am Soc Hematol Educ Program. 2008, 444-9.
8. Hamblin TJ (2007). Prognostic markers in chronic lymphocytic leukaemia. Best Pract Res Clin Haematol, 20, 455-68.
9. Idris M, Shah SH, Fareed J, Gul N (2004). An experience with sixty cases of haematological malignancies; a clinico haematological correlation. J Ayub Med Coll Abbottabad, 16, 51-4.
10. Kawamata N, Moreilhon C, Saitoh T, et al (2013). Genetic differences between Asian and Caucasian chronic lymphocytic leukemia. Int J Oncol, 43, 561-5.
11. Kermani IA, Dehdilani M, Dolatkhah R (2007). Chronic lymphocytic leukemia in the recent 10 years and treatment effects of fludarabin. Asian Pac J Cancer Prev, 8, 367-71.
12. Khan M, Saif A, Sandler S, Mirrakhimov AE (2014). Idelalisib for the treatment of chronic lymphocytic leukemia. ISRN Oncol, 2014, 931858.
13. Khalid A, Zahid M, Rehman A, et al (1997). Clinicoepidemiological features of adult leukemias in Pakistan. Pak Med Assoc, 47, 119-22.
14. Li ZJ, Qiu LG, Wu T, et al (2008). The clinical and laboratory features of 263 cases of chronic lymphocytic leukemia. Zhonghua Xue Ye Xue Za Zhi, 29, 300-3.
15. Maurer C, Hallek M (2013). Chronic lymphocytic leukemia. Dtsch Med Wochenschr, 138, 2153-66.
16. Mozaheb Z, Hasanzadeh NazarAbadi MH, Aghaee MA (2012). Chronic lymphocytic leukemia and prognostic factors. Asian Pac J Cancer Prev, 13, 3009-13.
17. Mukiibi JM, Paul B, Nyirenda CM, et al (2004). Chronic lymphocytic leukaemia (CLL) in Central Africans. Cent Afr J Med, 50, 111-5.
18. Omoti CE, Awodu OA, Bazuaye GN (2007).Chronic lymphoid leukaemia: clinico-haematological correlation and outcome in a single institution in Niger Delta region of Nigeria. Int J Lab Hematol, 29, 426-32.
19. Qi RJ, Zhang PH, Qiu LG, et al (2009). Clinical significance of ZAP-70 protein expression in chronic lymphocytic leukemia/ small lymphocytic lymphoma. Zhonghua Bing Li Xue Za Zhi, 38, 329-32.
20. Rafiq N, Iqbal T, Shahid M, Muhammad F (2014). Hematological and biochemical parameters in Pakistani chronic lymphoblastic leukemia patients. Pak J Life Soc Sci, 12, 16-19.
21. Redaelli A, Laskin BL, Stephens JM, Botteman MF, Pashos CL (2004). The clinical and epidemiological burden of chronic lymphocytic leukaemia. Eur J Cancer Care Engl, 13, 279-87.
22. Sagatys EM, Zhang L (2012). Clinical and laboratory prognostic indicators in chronic lymphocytic leukemia. Cancer Control, 19, 18-25.
23. Salawu L, Bolarinwa RA, Durosinmi MA (2010). Chronic lymphocytic leukaemia: a-twenty-years experience and problems in Ile-Ife, South-Western Nigeria. Afr Health Sci, 10, 187-92.
24. Sriphatphiriyakun T, Auewarakul CU (2005). Clinical presentation and outcome of Thai patients with chronic lymphocytic leukemia: retrospective analysis of 184 cases. Asian Pac J Allergy Immunol, 23, 197-203.
25. Tjønnfjord GE, Ly BE, Johannesen TB, et al (2012). Chronic lymphocytic leukaemia in Norway-incidence and prognostic markers at diagnosis. Tidsskr Nor Laegeforen, 132, 2056-9.
26. Vroblova V, Smolej L, Vrbacky F, et al (2009). Biological prognostic markers in chronic lymphocytic leukemia. Acta Medica Hradec Kralove, 52, 3-8.